0000914475-14-000094.txt : 20141215 0000914475-14-000094.hdr.sgml : 20141215 20141215192808 ACCESSION NUMBER: 0000914475-14-000094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141212 FILED AS OF DATE: 20141215 DATE AS OF CHANGE: 20141215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOLLICA JOSEPH A CENTRAL INDEX KEY: 0001126489 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 141288068 MAIL ADDRESS: STREET 1: 10555 SCIENCE CENTER DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-12-12 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001126489 MOLLICA JOSEPH A PO BOX 1182 PRINCETON NJ 08542 1 0 0 0 Common Stock 2014-12-12 4 M 0 20000 4.76 A 23508 D Common Stock 2014-12-12 4 F 0 4333 21.97 D 19175 D Stock Option 4.76 2014-12-12 4 M 0 20000 0 D 2007-06-28 2015-05-28 Common Stock 20000 0 D The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 28, 2008, which, if unexercised, would have expired on May 28, 2015. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's equity incentive plan. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($4.76) was subtracted from the December 12, 2014 market close price ($21.97), and this net amount ($17.21) was then multiplied by the number of options (20,000), with the resulting amount then divided by the market close price to result in a net issuance of 15,667 shares to the optionee. The 4,333 shares underlying the remaining portion of the options are not available for reissuance, and no shares are sold into the market as part of the exercise in connection with a net issuance program. Timothy P. Coughlin, By Power of Attorney 2014-12-15